Claire Friedel

Claire Friedel has a diverse work experience, starting in 2002 at Janssen-Cilag as a CRA coordinator for Medical Affairs. Claire then joined UCB pharma in 2004 as a Medical and Scientific Liaison until 2010. From 2010 to 2013, they worked as a Medical advisor at UCB pharma. Claire then transitioned to UCB in 2014, where they held the roles of Medical Education Manager Senior Consultant until 2015, and later as a Medical Manager for Parkinson Disease until 2017. In 2017, they joined BrainEver as a Global Project Leader and subsequently became the Chief Project Officer in 2019.

Claire Friedel completed their Executive MBA at ESCP Business School from 2019 to 2021. Prior to that, they pursued a DESS in Neurobiology & neuropsychology at Université Paris Cité from 2001 to 2002. Claire began their educational journey by attaining a Master's degree in Neurosciences from University Paris VI, which they obtained from 1998 to 2001.